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Abstract 
Aortic valve disease is a prevalent disorder that affects approximately 2% of the general adult population. Surgical aortic valve replace-
ment is the gold standard treatment for symptomatic patients. This treatment has demonstrably proven to be both safe and effective. Over the 
last few decades, in an attempt to reduce surgical trauma, different minimally invasive approaches for aortic valve replacement have been 
developed and are now being increasingly utilized. A narrative review of the literature was carried out to describe the surgical techniques for 
minimally invasive aortic valve surgery and report the results from different experienced centers. Minimally invasive aortic valve replace-
ment is associated with low perioperative morbidity, mortality and a low conversion rate to full sternotomy. Long-term survival appears to be 
at least comparable to that reported for conventional full sternotomy. Minimally invasive aortic valve surgery, either with a partial upper 
sternotomy or a right anterior minithoracotomy provides early- and long-term benefits. Given these benefits, it may be considered the stan-
dard of care for isolated aortic valve disease. 
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1  Introduction 
Minimally invasive aortic valve surgery (MI-AVS) is in-
creasingly being adopted by cardiac surgeons worldwide, 
and in some centers is becoming the standard of care.[1] The 
primary disease process for which patients are referred for 
aortic valve replacement (AVR) remains to be aortic steno-
sis. This population is generally older and therefore more 
likely to have concomitant co-morbidities compared to the 
mitral valve disease population. As such, AVR plays a cen-
tral role in MI-AVS. Improvements of the technique allow 
for expanded indications and improved outcomes.  
Since the first reported AVR occurred through a right 
thoracotomy in 1993,[2] a variety of techniques have been 
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described, including; parasternal,[3] infra-axillary,[4] lower 
hemi-sternotomy and transverse sternotomy.[5,6] Today, MI- 
AVS is performed primarily via upper mini-sternotomy (MS) 
or right anterior thoracotomy (RT) incisions (Figure 1).  
2  Patients selection and preoperative plan-
ning 
For patients requiring isolated valve surgery, the specific 
incision is tailored on the basis of comorbidities, morphol-
ogy of the valve, patient-specific anatomy and the surgeon’s 
preference. Most patients with a primary indication for aor-
tic valve surgery are amenable to a MI-AVS approach, 
however, it is worthwhile to consider contraindications or 
relative contraindications. Caution should be applied to pa-
tients with severe chest wall deformities, such as pectus 
excavatum and kyphoscoliosis, this can be considered both 
a relative contraindication depending on the severity of the 
abnormality.  
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Figure 1.  Schematic drawing showing the skin incision required for the J mini-sternotomy into the right fourth or third intercostal 
space (A) and for the right anterior thoracotomy incision in the third intercostal space (B). 
The need for coronary revascularization is not a contra-
indication to MI-AVS, and isolated lesions can be managed 
percutaneously, either before or after MI-AVS depending 
on clinical presentation. Emergency operations for acute 
aortic dissection are preferably performed through a full 
sternotomy because of the unpredictability of this condition. 
Reoperations are considered a relative contraindication for 
MI-AVS. If patients are selectively chosen (i.e., avoiding 
previous bypass surgery) and accurately planned, MI-AVS 
cam still be performed. 
Standard preoperative cardiac workup for MI-AVS is 
similar to conventional AVR. This includes chest radiogra-
phy, coronary angiography, routine laboratory studies and 
echocardiography. In a patient with a history of stroke or 
transient ischemic attack, duplex scanning of the carotid and 
vertebral arteries is warranted.  
Cardiac CT is often required, usually for patients with 
previous cardiac surgery, chest wall irradiation and all those 
being considered for right anterior thoracotomy.[7] This 
exam provides much precious information such as the loca-
tion of the aortic valve in the chest, anatomy of the valve, 
degree of calcification, size of the ascending aorta, distance 
between the posterior sternal table and right ventricle in 
redo surgery, in addition to aiding cannulation and 
cross-clamp strategies. 
3  Operative techniques  
Several minimally invasive approaches have been de-
veloped for AVR.[5] However, the most frequently adopted 
techniques are: (1) right anterior mini-thoracotomy (RT) 
and (2) upper mini-sternotomy (MS) with its variations (T-, 
J-, L-, reversed C-, S- and inverted V-shape). 
4  Mini-sternotomy  
Conduct of the operation for MS is similar to that of a 
full sternotomy aortic valve surgery, using standard instru-
ments and procedures (Figure 2).  
A 58 cm vertical skin incision is made just caudal to the 
sternal angle. The upper sternum is divided through a 
J-shaped incision with an oscillating saw, down to either the 
3rd or 4th right intercostal space depending on the patient 
body habitus. The pericardium is opened vertically and per-
icardial sutures are affixed 12 cm lateral to the skin edge. 
Doing so enhances exposure by displacing the aorta and 
heart anteriorly and cranially. The operative field is insuf-  
 
Figure 2.  View of the intraoperative field in a partial upper 
mini-sternotomy. 
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flated with carbon dioxide delivered through a catheter via a 
separate stab incision (later used for chest tube insertion). 
MI-AVS can be performed with either central or femoral 
cardiopulmonary bypass (CPB). Axillary arterial cannula-
tion is used selectively for those patients requiring ascend-
ing aorta replacement or in the presence of severe aortic 
calcification.  
To further increase the operative field, percutaneous 
femoral venous cannulation may be considered. The right 
common femoral vein is punctured via Seldinger technique 
and a venous cannula with multiple openings is advanced 
with its tip positioned 2 cm into the superior vena cava un-
der transesophageal echo (TEE) guidance. 
Delivery of cardioplegia can be performed using both 
antegrade and retrograde routes, similar to conventional 
aortic valve replacement. Left ventricular distension is pre-
vented by intermittent antegrade aortic root venting. After 
CBP is initiated, the aorta is occluded with a standard aortic 
cross-clamp. Other low-profile clamps can be used to 
maximize working space. A transverse aortotomy is placed 
slightly higher to facilitate its closure and visualization at 
the end of operation.  
The valve is replaced in standard fashion. Temporary 
epicardial wires are fixed to the decompressed right ventri-
cle before the aortic cross-clamp is removed. Because the 
surface of the heart is not readily accessible, de-airing de-
mands meticulous attention to detail and is monitored using 
TEE. Finally, surgical hemostasis is ensured, a single pericar-
dial drain is placed and the chest is closed using steel wires. 
5  Right anterior mini-thoracotomy 
In RT, the operative field is smaller and the aortic valve 
may sit deeper compare to the mini-sternotomy. Exposure is 
enhanced by minimizing cannula traffic within the incision, 
coupled with strategic placement of pericardial sutures. Be-
fore skin incision, peripheral cannulation is performed. A 
small oblique incision (4 cm) is made over the groin to ex-
pose the common femoral vessels anteriorly and a 40 
polypropylene purse-string sutures are placed. The femoral 
vein is first cannulated using the Seldinger technique and a 
multi-hole venous cannula is advanced with its tip posi-
tioned 2 cm into the superior vena cava under TEE guidance. 
Using the same percutaneous technique, the common femo-
ral artery is cannulated and its tip is positioned within the 
external iliac artery to avoid obstructing the internal iliac 
artery. Much like the upper mini-sternotomy approach, di-
rect aortic cannulation is the current preference in some 
centers (Figure 3).[8]  
 
Figure 3.  Right anterior mini-toracotomy for AVR. AVR: 
aortic valve replacement. 
A 46 cm skin incision is made over the right third in-
tercostal space near the sternal border. A soft tissue retractor 
is inserted into the wound followed by a rigid retractor. 
Pericardiotomy is performed 34 cm anterior and parallel to 
the phrenic nerve, extending inferiorly towards the dia-
phragm and superiorly to the pericardial reflection. The 
pericardium is retracted by passing sutures through the chest 
wall away from the incision. The operative field is insuf-
flated with carbon dioxide gas. The ascending aorta is 
clamped with a low-profile aortic cross-clamp and ante-
grade cold crystalloid or blood cardioplegia is delivered 
directly into the ascending aorta by a needle vent catheter.  
The aortic valve is replaced in usual fashion, however, 
longer handled instruments are utilized. Temporary epicar-
dial pacing wires may be placed before the aortic 
cross-clamp is removed. Once weaned from bypass, the 
femoral cannulae are removed. A small chest drainage tube 
is inserted in the right pleural space through a separate in-
tercostal space. The pericardium is approximated and the 
chest incision is closed routinely.  
6  Minimally invasive vs. conventional ster-
notomy aortic valve surgery 
Superiority of the minimally invasive approach, either 
MS or ST, over conventional aortic valve replacement has 
not been demonstrated yet. There is no consistent prospec-
tive studies published so far that can detect superiority of 
one of the approach over the other and identify patients who 
can benefits the most. 
Recent studies have demonstrated that MI-AVS is as safe 
as standard sternotomy, moreover it is associated with im-
provement in certain post-operative outcomes such as re-
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duced length of stay,[9] post-operative bleeding,[10] mechani-
cal intubation time,[10] and wound dehiscence.[11]  
The significantly lower use of blood products may also 
justify the reduction in renal failure reported in a recent 
meta-analysis.[12] The incidence of new onset atrial fibrilla-
tion (AF) after MI-AVS as compared to conventional AVR 
is a controversial topic due to the conflicting literature 
available on the matter.[8] Furthermore, economic benefits 
have been reported for the minimally invasive against con-
ventional sternotomy AVR.[13] 
Although MI-AVS has several positive outcomes, it is 
associated with longer aortic cross-clamp, CPB and operat-
ing times.[10] 
With regard to long term outcomes, Merk, et al.[14] re-
ported that MI-AVS was associated with an absolute in-
crease in postoperative survival of 7.5% and 4.9% at five 
and eight years respectively, when compared to conven-
tional AVR surgery. Glauber and colleagues also demon-
strated excellent survival in MI-AVS patients three years 
postoperatively (96% vs. 88% for conventional AVR), but 
this difference did not reach statistical significance;[8] simi-
larly one of the most experienced center in Europe also con-
firmed a good survival rate at 5-, 10- and 15-year, respec-
tively of 83.8% ± 1.1%, 69.4% ± 1.7% and 47.8% ± 4.7%.[15] 
An extremely important caveat for MI-AVS worth men-
tioning is the conversion rate to sternotomy. One study 
found that in expert hands, this drops to as low as 0.3%.[15] 
7  Minimally invasive mini-sternotomy vs. 
mini-thoracotomy 
Recently, an increasing number of studies in the litera-
ture have been comparing sternotomy versus RT or MS, but 
there is a lack in understanding as to whether there are sig-
nificant differences between these two minimally invasive 
approaches.[16] 
A recent Bayesian meta-analysis conducted by Phan, et 
al.[16] included seven randomized controlled trials and ten 
propensity-score matched observational studies showing 
that 30-day mortality, stroke, reoperation for bleeding and 
wound infection were comparable between the MS and the 
RT approach. The only difference found was a longer CPB 
and cross-clamp durations of a RT approach compared to 
MS, but that did not result in different operative and 
post-operative outcomes.   
Other authors have reported that the RT approach was 
significantly associated with improved post-operative out-
comes over MS, however sutureless technologies were used 
in the series.[17] In fact, recent reports described positive 
impact of sutureless and rapid deployment AVR on imme-
diate postoperative outcomes,[18] especially when MIAVR 
was performed;[19] however robust evidence is lacking on 
long-term outcomes.[20] 
8  The role of minimally invasive techniques 
in surgical AVR within the setting of TAVI 
Conventional surgical AVR remains the gold standard 
treatment for patients requiring AVR.  
Nevertheless, catheter-based procedures such as TAVI 
(trans aortic/apical/femoral valve implantation), are recom-
mended so far only in patients at high-risk for surgical AVR. 
The procedures have recently started to be considered even 
in the lower-risk groups.  
As an example, the PARTNER II trial aims to evaluate 
outcomes in patients with aortic stenosis and with The Soci-
ety of Thoracic Surgeons (STS) score of 4%6% undergo-
ing conventional aortic valve replacement and TAVI.[21] 
Patients with concomitant coronary artery disease will be 
randomized to percutaneous coronary intervention plus 
TAVI versus coronary artery bypass graft surgery plus AVR. 
Similarly, the Surgical Replacement and Trans-catheter 
Aortic Valve Implantation (SURTAVI) trial will include pa-
tients older than 70 years with an STS score of 3%8%.[21]  
Nevertheless, TAVI should, at present, be reserved only 
for high-risk patients or in particular conditions (e.g., porce-
lain aorta), whereas MI-AVS may be regarded as potential 
first line treatment. In a context of very old patients, the 
performance of MI-AVS was found to be excellent, even 
when MI-AVS was carried out in patients with very high 
EuroSCORE.[21]  
9  The expanding role of sutureless / fast re-
lease valves 
The potential benefits of minimally invasive valve sur-
gery may be enhanced by the use of the sutureless / fast 
release valve technologies. As highlighted before, the main 
drawback of MI-AVS lies in the increased CPB and cross 
clamp time. Sutureless valves in fact aim to reduce opera-
tive time by using rapid valve deployment techniques. In the 
TRITON trial, the CPB and cross-clamp times were 75 min 
and 46.6 min respectively.[21] The use of Perceval S and 
ATS 3f Enable has demonstrated similar reduction in by-
pass times of less than 30 min. Comparison with STS data 
shows a 60% decrease in operative time, which might re-
duce the effects on myocardial ischemia and hypoxia.[21] 
10  Clinical perspectives 
Since minimally invasive aortic valve surgery may con-
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fer better outcomes than standard sternotomy, an increasing 
effort to offer such an approach to high-risk patients should 
be encouraged. Potentially, these high risk patients are the 
ones who may benefit the most as demonstrated, for exam-
ple, as in the case of mitral minimally invasive surgery.[22,23] 
The use of sutureless technologies also has to be encouraged 
since it may reduce the operative time.  
11  Conclusions 
Current evidence suggests that MI-AVS is associated 
with excellent early and late outcomes that are at least 
comparable to full sternotomy. At present, MI-AVS is per-
formed primarily via mini-sternotomy or right anterior tho-
racotomy incisions. The mini-sternotomy affords the sur-
geon a “familiar exposure” and may not require special in-
struments, and thus reducing the learning curve compared to 
a mini-thoracotomy approach. Continual improvements 
facilitated by the development of sutureless or rapid de-
ployment prostheses in addition to continuing popularity 
can make minimally invasive valve surgery a staple for fu-
ture cardiac surgery. 
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